Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01733355 · ClinicalTrials.gov registry record · Early Phase 1

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

A Early Phase 1 study, sponsored by Avid Radiopharmaceuticals.

Terminated
Registry status
Early Phase 1
Development phase
11
Enrollment target

NCT01733355: Clinical Trial Early Phase 1 study, sponsored by Avid Radiopharmaceuticals.

NCT01733355 is a Early Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01733355, a Early Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.

TERMINATED
Registry status
Early Phase 1
Development phase
11 participants
Enrollment target

Study Summary

\[F-18\]T807 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

Interventions

  • RADIATION [F18] T807

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2012-07
Est. Completion 2013-03
Phase Early Phase 1
Avid Radiopharmaceuticals

42 total trials

Why NCT01733355 stopped before completion

NCT01733355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which [F18] T807 is the first listed.

NCT01733355 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01733355 about?

NCT01733355 is a clinical study titled "A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807". \[F-18\]T807 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

What is the current status of trial NCT01733355?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2012-07. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01733355?

The interventions under investigation include: [F18] T807 (RADIATION).

Who is sponsoring clinical trial NCT01733355?

This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01733355's enrollment target sits among peer trials

11 1600th of 2000 higher than 373 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01733355, the US trial registry maintained by the National Library of Medicine. NCT01733355 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.